Advertisement

Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis

  • Ertugrul KiykimEmail author
  • Kenan Barut
  • Mehmet Serif Cansever
  • Cigdem Aktuglu Zeybek
  • Tanyel Zubarioglu
  • Ahmet Aydin
  • Ozgur Kasapcopur
Research Report
Part of the JIMD Reports book series (JIMD, volume 25)

Abstract

Mucopolysaccharidosis is a group of lysosomal disorders of a deficiency of specific enzyme required for glycosaminoglycan degradation. Mucopolysaccharidosis type IX is the rarest form of mucopolysaccharidosis. To date, only four patients have been reported. The first reported patient had mild short stature and periarticular soft tissue masses; the other reported patients are clinically indistinguishable from juvenile idiopathic arthritis. In the present study, we screened mucopolysaccharidosis type IX among patients with juvenile idiopathic arthritis with hyaluronidase enzyme assay. One hundred and eight patients with JIA and 50 healthy age-matched control subjects were enrolled in the study. Among all patients, none had deficient hyaluronidase activity. Though serum Hyal-1 activity was significantly increased in JIA patients, compared with control subjects (p < 0.000), no correlation was found between CRP, ESR, and Hyal-1 activity (p = 0.187). In conclusion, the data reported in our study indicates that systemic metabolic investigation for hyaluronidase activity is not recommended in all patients with JIA.

Keywords

Hyaluronidase deficiency Juvenile idiopathic arthritis Mucopolysaccharidosis type IX 

References

  1. Fiszer-Szafarz B, Czartoryska B, Tylki-Szymanska A (2005) Serum hyaluronidase aberrations in metabolic and morphogenetic disorders. Glycoconj J 22(7-9):395–400CrossRefPubMedGoogle Scholar
  2. Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34(7):799–807CrossRefPubMedGoogle Scholar
  3. Imundo L, Leduc CA, Guha S et al (2011) A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis. J Inherit Metab Dis 34(5):1013–1022CrossRefPubMedGoogle Scholar
  4. Jadin L, Wu X, Ding H et al (2008) Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX? FASEB J 22(12):4316–4326CrossRefPubMedGoogle Scholar
  5. Kunder EV (2010) Criteria for the differential diagnosis of spondyloarthropathies, by determining serum hyaluronidase activity. Klin Lab Diagn 4:10–12PubMedGoogle Scholar
  6. Martin DC, Atmuri V, Hemming RJ et al (2008) A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis. Hum Mol Genet 17(13):1904–1915Google Scholar
  7. Nagaya H, Ymagata T, Ymagata S et al (1999) Examination of synovial fluid and serum hyaluronidase activity as a joint marker in rheumatoid arthritis and osteoarthritis patients (by zymography). Ann Rheum Dis 58(3):186–188CrossRefPubMedPubMedCentralGoogle Scholar
  8. Natowicz MR, Wang Y (1996) Human serum hyaluronidase: characterization of a clinical assay. Clin Chim Acta 245:1–6CrossRefPubMedGoogle Scholar
  9. Natowicz MR, Short MP, Wang Y et al (1996) Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med 335(14):1029–1033Google Scholar
  10. Neufeld EF, Muenzer J (2001) In: Scriver, C. Beaudet, A. Sly, W. and Valle, D (eds) The metabolic and molecular mechanisms of inherited disease, McGraw-Hill, New York, pp 3421–3452Google Scholar
  11. Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M (1991) Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 34(7):815–821CrossRefPubMedGoogle Scholar
  12. Petty RE, Southwood TR, Manners P et al (2004) International league of associations for rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390–392PubMedGoogle Scholar
  13. Reissig JL, Storminger JL, Leloir LF (1955) A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem 217(2):959–966PubMedGoogle Scholar
  14. Triggs-Raine B, Salo TJ, Zhang H, Wicklow BA, Natowicz MR (1999) Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. Proc Natl Acad Sci U S A 96(11):6296–6300Google Scholar
  15. Wraith JE (1995) The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child 72(3):263–267CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Ertugrul Kiykim
    • 1
    Email author
  • Kenan Barut
    • 2
  • Mehmet Serif Cansever
    • 3
  • Cigdem Aktuglu Zeybek
    • 1
  • Tanyel Zubarioglu
    • 1
  • Ahmet Aydin
    • 1
  • Ozgur Kasapcopur
    • 2
  1. 1.Division of Nutrition and Metabolism, Department of Pediatrics, Cerrahpasa Medical FacultyIstanbul UniversityIstanbulTurkey
  2. 2.Division of Rheumatology, Department of Pediatrics, Cerrahpasa Medical FacultyIstanbul UniversityIstanbulTurkey
  3. 3.Central LaboratoryIstanbul University, Cerrahpasa MedicalIstanbulTurkey

Personalised recommendations